Russia to deliver COVID-19 drug to South Africa, Latin American countries: Wealth fund
150,000 packs of Avifavir would be sent to several countries
Also In This Package
Top 3 leading vaccines from China: Phase III trials
Hydroxychloroquine and azithromycin: COVID-19 antidote?
Want to volunteer for COVID-19 clinical trials in UAE?
Top 5: Coronavirus 'vaccine candidates'
Photos: Coronavirus vaccine test opens with 1st doses
Trump relaunches election campaign with vaccine promise
MOSCOW: Russia has signed deals to supply South Africa and seven Latin American countries with an anti-viral drug Russian authorities have approved to treat COVID-19, its sovereign wealth fund said on Monday.
The Russian Direct Investment Fund (RDIF) said that at least 150,000 packs of the drug, known as Avifavir, would be sent to Argentina, Bolivia, Ecuador, El Salvador, Honduras, Paraguay and Uruguay. The drug will also be supplied to South Africa, RDIF said in a statement.
Also Read
COVID-19: How Indians in the UAE can apply for a fine waiverCOVID -19: European summit has a different look with masked up world leaders COVID-19 testing: Thousands cram into stadium in ManilaPhotos: Teddy bears help to maintian social distancing at a Mexican restaurantTechnology to make the drug would be transferred to Bolivia's Sigma Corp S.R.L. for it to be produced locally, RDIF said.
The Russian health ministry gave its approval for the drug's use under a special accelerated process in May.
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox
Network Links
GN StoreDownload our app
© Al Nisr Publishing LLC 2026. All rights reserved.